Clinical observation study of 5-year survivals in patients with newly diagnosed acute lymphoblastic leukemia (ALL) in Japan Adult Leukemia Study Group (JALSG). (JALSG-ALL-CS-12)
Not Applicable
- Conditions
- Acute lymphoblastic leukemia
- Registration Number
- JPRN-UMIN000007653
- Lead Sponsor
- Japan Agency for Medical Research and Development Japan Adult Leukemia Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 733
Inclusion Criteria
Not provided
Exclusion Criteria
Past history of chemotherapy or stem cell transplantation in the treatment of A
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) ALL patient 5-year survivals (2) Effect of stem cell transplantation (SCT) on ALL patients (3) Effect of timing of SCT and conditioning regimen on ALL patients (4) Numbers of patients with ALL by age group, sex and type of diseases (5) Feasibility of classification according to known prognostic factors (6) Description of patients' status in chemotherapy program (7) Remission duration due to chemotherapy
- Secondary Outcome Measures
Name Time Method